Ergosterol utilizes PDE4B and PDE4D, and adenosine targets PARP1, PTGDR2, PDE4A, PDE4B, PDE4C, PDE4D, and HMOX1 as co‐targeted proteins in the therapeutic approach for COPD. The gene discussed is PTGDR2; the disease is chronic obstructive pulmonary disease.